Noradrenaline (Norepinephrine) Kabi (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Noradrenaline Kabi, is an adrenergic agonist presented as an injection solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in patients experiencing severe hypotension, septic shock, or cardiac arrest.

GNH USA supplies Noradrenaline Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for this critical care medication, ensuring timely delivery to emergency departments and intensive care units.

Noradrenaline acts on the adrenergic system to restore vascular tone and cardiac output in critical care settings.

- Hypotension: increases systemic vascular resistance to maintain adequate blood pressure. - Septic shock: restores perfusion pressure in distributive shock. - Cardiac arrest: supports coronary and cerebral perfusion during resuscitation.

Norepinephrine may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Tachycardia: increased heart rate due to β1 stimulation. - Hypertension: excessive rise in blood pressure from α1 vasoconstriction. - Arrhythmias: irregular heart rhythms, especially in susceptible patients. - Peripheral ischemia: reduced blood flow to extremities causing coldness or pain.

Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary perfusion leading to chest pain or infarction. - Tissue necrosis: severe extravasation causing local tissue death. - Severe hypertension crisis: dangerously high blood pressure requiring immediate intervention.

When using norepinephrine, clinicians should observe several precautionary measures to ensure safety and efficacy. - Monitor blood pressure: adjust infusion to maintain target MAP. - Assess cardiac function: watch for tachyarrhythmias and ischemia. - Use central venous access: avoid extravasation and local tissue injury. - Caution in peripheral vascular disease: risk of compromised limb perfusion. - Review concomitant medications: especially MAO inhibitors and other pressor agents. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other agents, influencing its pressor effect or safety profile.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Tricyclic antidepressants: additive pressor effect increasing risk of severe hypertension. - Beta‑blockers: may blunt desired cardiovascular response.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin, nitroprusside): may require higher norepinephrine doses. - Calcium channel blockers: can enhance cardiovascular effects. - General anesthetics: may alter hemodynamic stability during surgery.